Connection

Brian Hess to Immunotherapy, Adoptive

Back to Details
This is a "connection" page, showing publications Brian Hess has written about Immunotherapy, Adoptive.
Brian Hess
Connection Strength
0.287
Immunotherapy, Adoptive
  1. Gastric adenocarcinoma following CD19-directed chimeric antigen receptor T cell therapy. Ann Hematol. 2023 02; 102(2):461-462.
    View in: PubMed
    Score: 0.192
  2. Fever Characteristics and Impact on Safety and Efficacy of Chimeric Antigen Receptor T-Cell Therapy. Clin Lymphoma Myeloma Leuk. 2023 01; 23(1):e14-e18.
    View in: PubMed
    Score: 0.048
  3. Real-World Experience and Optimization of Outpatient Chimeric Antigen Receptor T Cell Therapy. Transplant Cell Ther. 2022 09; 28(9):583-585.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.